Materials Healthcare Sector

PepGen

Market Cap: US$47.8m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

Radius Residential Care

Market Cap: NZ$79.7m

Provides health and aged care services for elderly and disabled people in New Zealand.

Artiva Biotherapeutics

Market Cap: US$47.5m

A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.

Mural Oncology

Market Cap: US$47.5m

Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.

OpGen

Market Cap: US$47.3m

A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.

OS Therapies

Market Cap: US$47.2m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

PMV Pharmaceuticals

Market Cap: US$47.1m

A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.

Sernova Biotherapeutics

Market Cap: CA$64.1m

Operates as a clinical-stage biotechnology company in Canada.

Apiam Animal Health

Market Cap: AU$71.7m

A vertically integrated animal health company, provides veterinary products and services to production and companion animals, and equine in Australia.

Opus Genetics

Market Cap: US$46.4m

A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs).

Adverum Biotechnologies

Market Cap: US$46.2m

A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.

EZZ Life Science Holdings

Market Cap: AU$71.0m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

Zomedica

Market Cap: US$46.1m

A veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals.

Anebulo Pharmaceuticals

Market Cap: US$46.0m

A clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.

ANGLE

Market Cap: UK£33.9m

A medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally.

Xilio Therapeutics

Market Cap: US$45.8m

A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.

BioNxt Solutions

Market Cap: CA$62.5m

Engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability.

Maverick Lifestyle

Market Cap: US$45.4m

Engages in the manufacture, branding, marketing, distribution, and sale of products infused with hemp-derived cannabinoids in the United States.

Medical Developments International

Market Cap: AU$69.8m

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

Modular Medical

Market Cap: US$45.3m

Operates as a medical device company.

Rein Therapeutics

Market Cap: US$45.1m

A biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.

Firefly Neuroscience

Market Cap: US$44.5m

A medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders.

NRx Pharmaceuticals

Market Cap: US$44.3m

A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.

House of Jane

Market Cap: US$44.1m

Provides lifestyle therapy products.

Mersana Therapeutics

Market Cap: US$43.9m

A clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs.

Microba Life Sciences

Market Cap: AU$67.2m

Provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.

RenovoRx

Market Cap: US$43.5m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

MedMira

Market Cap: CA$59.6m

A biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally.

Neurizon Therapeutics

Market Cap: AU$66.5m

A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally.

Actinogen Medical

Market Cap: AU$65.8m

A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.

Atara Biotherapeutics

Market Cap: US$42.6m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

Hyperfine

Market Cap: US$42.4m

A health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.

ImpediMed

Market Cap: AU$64.8m

A medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe.

Kronos Bio

Market Cap: US$42.0m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States.

Connect Biopharma Holdings

Market Cap: US$41.8m

A clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases.

Nowtransit

Market Cap: US$41.6m

Distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses.